J Gastric Cancer.  2016 Dec;16(4):230-239. 10.5230/jgc.2016.16.4.230.

Postoperative Quality of Life after Total Gastrectomy Compared with Partial Gastrectomy: Longitudinal Evaluation by European Organization for Research and Treatment of Cancer-OG25 and STO22

• Lee JH
• Lee HJ
• Choi YS
• Kim TH
• Huh YJ
• Suh YS
• Kong SH
• Yang HK

• KMID: 2389848
• DOI: http://doi.org/10.5230/jgc.2016.16.4.230

Abstract

PURPOSE
The European Organization for Research and Treatment of Cancer quality-of-life questionnaire-OG25 was developed to evaluate the quality of life in patients with stomach and esophageal cancer. The following are included in the OG25 but not in the STO22: odynophagia, choked when swallowing, weight loss, trouble eating with others, trouble swallowing saliva, trouble talking, and trouble with coughing. In this study, we evaluated the quality of life of gastrectomized patients using both, the OG25 and the STO22.
MATERIALS AND METHODS
A total of 138 patients with partial gastrectomy (PG) (distal gastrectomy=91; pylorus-preserving gastrectomy= 47) and 44 patients with total gastrectomy (TG) were prospectively evaluated. Body weight and scores from the OG25 and STO22 were evaluated preoperatively and at 3 weeks, 3 months, and 6 months after surgery.
RESULTS
Patients with TG had significant weight loss compared to patients with PG. At 3 months, TG was associated with worse scores for dysphagia, eating, odynophagia, trouble eating with others, trouble with taste, and weight loss on the OG25. TG was also associated with dysphagia, eating restrictions, and anxiety on the STO22. The OG25 helped differentiate between the groups with respect to weight loss, odynophagia, choked when swallowing, and trouble eating with others. The OG25 scores changed over time and were significantly different.
CONCLUSIONS
The OG25 is a more sensitive and useful scale than the STO22 for evaluating the quality of life of gastrectomized patients, especially those with total gastrectomy.

Keyword

Stomach neoplasms; Quality of life; Gastrectomy; EORTC; OG-25

MeSH Terms

Anxiety
Body Weight
Cough
Deglutition
Deglutition Disorders
Eating
Esophageal Neoplasms
Gastrectomy*
Humans
Prospective Studies
Quality of Life*
Saliva
Stomach
Stomach Neoplasms
Weight Loss

Figure

• 

  Fig. 1 TG showed significantly more weight loss compared to PG. PG = partial gastrectomy; TG = total gastrectomy. *Significant differences (P<0.001).

• 

  Fig. 2 Scales discriminating total from partial gastrectomy with the OG25. (A) Odynophagia. (B) Weight loss. (C) Checked when swallowing. (D) Eating with others. PG = partial gastrectomy; TG = total gastrectomy; Preop. = preoperative.

Reference

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011; 61:69–90.

2. Van Cutsem E, Sagaert X, Topal B, Haustermans K, Prenen H. Gastric cancer. Lancet. 2016; DOI: 10.1016/S0140-6736(16)30354-3. [In print].

3. Jeong O, Park YK. Clinicopathological features and surgical treatment of gastric cancer in South Korea: the results of 2009 nationwide survey on surgically treated gastric cancer patients. J Gastric Cancer. 2011; 11:69–77.

4. Jung KW, Won YJ, Oh CM, Kong HJ, Cho H, Lee DH, et al. Prediction of cancer incidence and mortality in Korea, 2015. Cancer Res Treat. 2015; 47:142–148.

5. Kobayashi D, Kodera Y, Fujiwara M, Koike M, Nakayama G, Nakao A. Assessment of quality of life after gastrectomy using EORTC QLQ-C30 and STO22. World J Surg. 2011; 35:357–364.

6. Macintyre IM, Akoh JA. Improving survival in gastric cancer: review of operative mortality in English language publications from 1970. Br J Surg. 1991; 78:771–776.

7. Maruyama K, Okabayashi K, Kinoshita T. Progress in gastric cancer surgery in Japan and its limits of radicality. World J Surg. 1987; 11:418–425.

8. Korenaga D, Tsujitani S, Haraguchi M, Okamura T, Tamada R, Sugimachi K, et al. Long-term survival in Japanese patients with far advanced carcinoma of the stomach. World J Surg. 1988; 12:236–240.

9. Köckerling F, Reck T, Gall FP. Extended gastrectomy: who benefits? World J Surg. 1995; 19:541–545.

10. McCall MD, Graham PJ, Bathe OF. Quality of life: a critical outcome for all surgical treatments of gastric cancer. World J Gastroenterol. 2016; 22:1101–1113.

11. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993; 85:365–376.

12. Sprangers MA, Cull A, Groenvold M, Bjordal K, Blazeby J, Aaronson NK. EORTC quality of life study group. The European organization for research and treatment of cancer approach to developing questionnaire modules: an update and overview. Qual Life Res. 1998; 7:291–300.

13. Kaasa S, Bjordal K, Aaronson N, Moum T, Wist E, Hagen S, et al. The EORTC core quality of life questionnaire (QLQ-C30): validity and reliability when analysed with patients treated with palliative radiotherapy. Eur J Cancer. 1995; 31A:2260–2263.

14. van der Schaaf M, Derogar M, Lagergren P. Reference values of oesophago-gastric symptoms (EORTC QLQ-OG25) in a population-based setting. Eur J Cancer. 2012; 48:1602–1607.

15. Fayers P, Bottomley A. EORTC Quality of Life Group. Quality of Life Unit. Quality of life research within the EORTC-the EORTC QLQ-C30. European organisation for research and treatment of cancer. Eur J Cancer. 2002; 38:Suppl 4. S125–S133.

16. Botterweck AA, Schouten LJ, Volovics A, Dorant E, van Den Brandt PA. Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int J Epidemiol. 2000; 29:645–654.

17. Ferro A, Peleteiro B, Malvezzi M, Bosetti C, Bertuccio P, Levi F, et al. Worldwide trends in gastric cancer mortality (1980-2011), with predictions to 2015, and incidence by subtype. Eur J Cancer. 2014; 50:1330–1344.

18. Tomaszewski KA, Püsküllüoğlu M, Biesiada K, Bochenek J, Nieckula J, Krzemieniecki K. Validation of the polish version of the eortc QLQ-C30 and the QLQ-OG25 for the assessment of health-related quality of life in patients with esophagi-gastric cancer. J Psychosoc Oncol. 2013; 31:191–203.

19. Kim AR, Cho J, Hsu YJ, Choi MG, Noh JH, Sohn TS, et al. Changes of quality of life in gastric cancer patients after curative resection: a longitudinal cohort study in Korea. Ann Surg. 2012; 256:1008–1013.

20. Oñate-Ocaña LF, Velázquez-Monroy N, Vázquez L, Espinosa-Mireles-de-Villafranca P, Núñez-Rosas E, Ovando-Lezama M, et al. Clinical validation of the EORTC QLQ-OG25 questionnaire for the evaluation of health-related quality of life in Mexican patients with esophagogastric cancers. Psychooncology. 2012; 21:745–753.

21. Nakada K, Ikeda M, Takahashi M, Kinami S, Yoshida M, Uenosono Y, et al. Characteristics and clinical relevance of post-gastrectomy syndrome assessment scale (PGSAS)-45: newly developed integrated questionnaires for assessment of living status and quality of life in postgastrectomy patients. Gastric Cancer. 2015; 18:147–158.